NO975176L - Fremgangsmåte ved fremstilling av lercanidipin-hydroklorid - Google Patents

Fremgangsmåte ved fremstilling av lercanidipin-hydroklorid

Info

Publication number
NO975176L
NO975176L NO975176A NO975176A NO975176L NO 975176 L NO975176 L NO 975176L NO 975176 A NO975176 A NO 975176A NO 975176 A NO975176 A NO 975176A NO 975176 L NO975176 L NO 975176L
Authority
NO
Norway
Prior art keywords
preparation
lercanidipine hydrochloride
lercanidipine
hydrochloride
Prior art date
Application number
NO975176A
Other languages
English (en)
Other versions
NO975176D0 (no
NO309423B1 (no
Inventor
Amedeo Leonardi
Gianni Motta
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NO975176L publication Critical patent/NO975176L/no
Publication of NO975176D0 publication Critical patent/NO975176D0/no
Publication of NO309423B1 publication Critical patent/NO309423B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO975176A 1995-05-12 1997-11-11 Fremgangsmåte ved fremstilling av lercanidipinhydroklorid NO309423B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI950957A IT1274480B (it) 1995-05-12 1995-05-12 Procedimento migliorato per la preparazione della lercanidipina cloridrato
PCT/EP1996/002122 WO1996035668A1 (en) 1995-05-12 1996-05-09 A process for the preparation of lercanidipine hydrochloride

Publications (3)

Publication Number Publication Date
NO975176L true NO975176L (no) 1997-11-11
NO975176D0 NO975176D0 (no) 1997-11-11
NO309423B1 NO309423B1 (no) 2001-01-29

Family

ID=11371581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975176A NO309423B1 (no) 1995-05-12 1997-11-11 Fremgangsmåte ved fremstilling av lercanidipinhydroklorid

Country Status (37)

Country Link
EP (1) EP0824517B1 (no)
JP (1) JP4038622B2 (no)
KR (1) KR100395441B1 (no)
CN (1) CN1101810C (no)
AR (1) AR002739A1 (no)
AT (1) ATE221050T1 (no)
AU (1) AU694046B2 (no)
BG (1) BG62400B1 (no)
BR (1) BR9608374A (no)
CA (1) CA2217849C (no)
CZ (1) CZ288634B6 (no)
DE (1) DE69622552T2 (no)
DK (1) DK0824517T3 (no)
DZ (1) DZ2032A1 (no)
EA (1) EA000346B1 (no)
EE (1) EE03351B1 (no)
EG (1) EG21755A (no)
ES (1) ES2179942T3 (no)
HU (1) HU226709B1 (no)
IL (1) IL118143A (no)
IN (1) IN188486B (no)
IT (1) IT1274480B (no)
MA (1) MA23858A1 (no)
MX (1) MX9708662A (no)
MY (1) MY113802A (no)
NO (1) NO309423B1 (no)
NZ (1) NZ309059A (no)
PL (1) PL185260B1 (no)
PT (1) PT824517E (no)
RO (1) RO119616B1 (no)
SA (1) SA96170216B1 (no)
SK (1) SK283321B6 (no)
TN (1) TNSN96069A1 (no)
TW (1) TW404940B (no)
UA (1) UA46769C2 (no)
WO (1) WO1996035668A1 (no)
ZA (1) ZA963716B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
AU2003274004A1 (en) * 2002-10-16 2004-05-04 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR100713136B1 (ko) * 2005-05-04 2007-05-02 주식회사 대희화학 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법
SI1891009T1 (sl) * 2005-06-15 2010-02-26 Hetero Drugs Ltd Hetero House Nov postopek priprave lerkanidipina
US8097729B2 (en) 2005-09-16 2012-01-17 Glenmark Generics Ltd. Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
KR100811497B1 (ko) * 2005-10-19 2008-03-07 신풍제약주식회사 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법
DE602006003877D1 (de) * 2006-05-24 2009-01-08 Cf Pharma Ltd Verfahren zur Herstellung von Lercanipidin
KR100808281B1 (ko) * 2006-06-30 2008-03-03 주식회사 하원정밀화학 레르카니디핀 및 그 산부가염의 제조방법
CN102020602B (zh) * 2009-09-18 2013-12-25 深圳信立泰药业股份有限公司 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物
EP2585051B2 (en) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
EP2654729B1 (en) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
CN102516160B (zh) * 2011-12-16 2014-04-02 华润赛科药业有限责任公司 一种高纯盐酸乐卡地平的合成工艺
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102584682A (zh) * 2011-12-31 2012-07-18 苏州二叶制药有限公司 盐酸乐卡地平的制备方法
CN109956943B (zh) * 2019-04-18 2021-07-20 合肥合源药业有限公司 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
TW404940B (en) 2000-09-11
HU226709B1 (en) 2009-07-28
ITMI950957A0 (it) 1995-05-12
ATE221050T1 (de) 2002-08-15
ES2179942T3 (es) 2003-02-01
RO119616B1 (ro) 2005-01-28
DE69622552T2 (de) 2003-01-23
ITMI950957A1 (it) 1996-11-12
CN1184468A (zh) 1998-06-10
EP0824517B1 (en) 2002-07-24
BG102034A (en) 1998-04-30
CN1101810C (zh) 2003-02-19
IL118143A (en) 2001-06-14
HUP9801913A3 (en) 1999-01-28
TNSN96069A1 (fr) 2005-03-15
WO1996035668A1 (en) 1996-11-14
KR100395441B1 (ko) 2004-02-05
EG21755A (en) 2002-02-27
ZA963716B (en) 1996-11-20
PT824517E (pt) 2002-12-31
CZ356797A3 (cs) 1998-04-15
AU5898596A (en) 1996-11-29
AR002739A1 (es) 1998-04-29
BG62400B1 (bg) 1999-10-29
AU694046B2 (en) 1998-07-09
CA2217849A1 (en) 1996-11-14
NZ309059A (en) 1998-10-28
KR19990008378A (ko) 1999-01-25
MA23858A1 (fr) 1996-12-31
EE03351B1 (et) 2001-02-15
MX9708662A (es) 1998-08-30
IT1274480B (it) 1997-07-17
IN188486B (no) 2002-10-05
DK0824517T3 (da) 2002-11-18
DE69622552D1 (de) 2002-08-29
MY113802A (en) 2002-05-31
JPH11504932A (ja) 1999-05-11
BR9608374A (pt) 1999-08-24
SK283321B6 (sk) 2003-06-03
PL323236A1 (en) 1998-03-16
UA46769C2 (uk) 2002-06-17
CZ288634B6 (cs) 2001-08-15
NO975176D0 (no) 1997-11-11
EA000346B1 (ru) 1999-04-29
DZ2032A1 (fr) 2002-07-21
HUP9801913A2 (hu) 1998-12-28
EP0824517A1 (en) 1998-02-25
EA199700374A1 (ru) 1998-10-29
SA96170216B1 (ar) 2005-12-21
PL185260B1 (pl) 2003-04-30
IL118143A0 (en) 1996-09-12
NO309423B1 (no) 2001-01-29
SK151497A3 (en) 1998-05-06
JP4038622B2 (ja) 2008-01-30
CA2217849C (en) 2007-09-11

Similar Documents

Publication Publication Date Title
NO970939D0 (no) Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
NO994771D0 (no) FremgangsmÕte ved fremstilling av oligosakkarider
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO975176L (no) Fremgangsmåte ved fremstilling av lercanidipin-hydroklorid
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
NO965113D0 (no) Fremgangsmåte ved fremstilling av et steroid-ketalderivat
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO964482L (no) Fremgangsmåte ved fremstilling av doxorubicin
NO955082D0 (no) Fremgangsmåte for fremstilling av glutardialdehyd
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO962940D0 (no) Fremgangsmåte ved hydroisomerisering
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO304883B1 (no) FremgangsmÕte ved fremstilling av hydrazin-nitroform
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO953459L (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
FI960790A (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
NO970043D0 (no) Fremgangsmåte for fremstilling av 5-aryl-2,4-dialkyl-3H-1,2,4-triazol-3-thioner

Legal Events

Date Code Title Description
MK1K Patent expired